Amplyx Pharmaceuticals (Series B, Series C, Series C Extension)

Funding Details
Awarder
Inbox
Date Award
November 11, 2015
Vertical
Pharmaceuticals
Funding URL
View Funding Page
Funding Amount:
$53,000,000

Company Info
Company Description
Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems
Market
Antifungal agents for life-threatening fungal infections
Location
San Diego, California, USA
Coinvestors
BioMed Ventures, RiverVest Venture Partners, 3x5 Partners, Arix Bioscience, Lundbeckfond Ventures, Pappas Ventures, Sofinnova Ventures, Adage Capital Management, New Enterprise Associates, Pfizer Venture Investments, Pappas Capital

Links